ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue”

September 14, 1984

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

In Brief: John Minton Dies Forom Auto Accident Injuries; FDA Rules Against Generic Megastrol Acetate

January 11, 1991

Waxman Hearing Turns Out Strong Support For Cancer Program Renewal

February 29, 1980

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987

NCI to Fund 122 More Grants in FY04

March 28, 2003